The stock of Compugen Ltd (CGEN) has gone up by 11.11% for the week, with a 9.59% rise in the past month and a -31.33% drop in the past quarter. The volatility ratio for the week is 5.62%, and the volatility levels for the past 30 days are 7.79% for CGEN. The simple moving average for the past 20 days is 15.65% for CGEN’s stock, with a -9.03% simple moving average for the past 200 days.
Is It Worth Investing in Compugen Ltd (NASDAQ: CGEN) Right Now?
The 36-month beta value for CGEN is at 2.64. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CGEN is 91.53M, and currently, shorts hold a 2.01% of that float. The average trading volume for CGEN on May 01, 2025 was 379.09K shares.
CGEN) stock’s latest price update
Compugen Ltd (NASDAQ: CGEN)’s stock price has gone rise by 14.29 in comparison to its previous close of 1.40, however, the company has experienced a 11.11% increase in its stock price over the last five trading days. prnewswire.com reported 2025-03-26 that HOLON, Israel, March 26, 2025 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will participate in the following upcoming virtual investor conferences in April 2025: H.C.
Analysts’ Opinion of CGEN
Many brokerage firms have already submitted their reports for CGEN stocks, with Oppenheimer repeating the rating for CGEN by listing it as a “Outperform.” The predicted price for CGEN in the upcoming period, according to Oppenheimer is $4 based on the research report published on January 13, 2025 of the current year 2025.
Jefferies, on the other hand, stated in their research note that they expect to see CGEN reach a price target of $2. The rating they have provided for CGEN stocks is “Hold” according to the report published on August 05th, 2022.
JMP Securities gave a rating of “Mkt Outperform” to CGEN, setting the target price at $18 in the report published on May 26th of the previous year.
CGEN Trading at 0.91% from the 50-Day Moving Average
After a stumble in the market that brought CGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.85% of loss for the given period.
Volatility was left at 7.79%, however, over the last 30 days, the volatility rate increased by 5.62%, as shares surge +13.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.82% lower at present.
During the last 5 trading sessions, CGEN rose by +11.11%, which changed the moving average for the period of 200-days by -9.09% in comparison to the 20-day moving average, which settled at $1.3835. In addition, Compugen Ltd saw 4.58% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CGEN
Current profitability levels for the company are sitting at:
- -0.53 for the present operating margin
- 0.72 for the gross margin
The net margin for Compugen Ltd stands at -0.51. The total capital return value is set at -0.16. Equity return is now at value -23.63, with -12.04 for asset returns.
Currently, EBITDA for the company is -14.4 million with net debt to EBITDA at 1.03. When we switch over and look at the enterprise to sales, we see a ratio of 4.82. The receivables turnover for the company is 103.58for trailing twelve months and the total asset turnover is 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.26.
Conclusion
In conclusion, Compugen Ltd (CGEN) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
